Last reviewed · How we verify
NCT03995602
The Effects of Dragon Fruit Consumption on Vascular Function.
NA trial testing Dragon fruit juice drink in Healthy Men and Women in 20 participants. Completed in 22 January 2020.
22 January 2020
Quick facts
| Lead sponsor | King's College London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | triple |
| Primary purpose | basic science |
| Enrollment | 20 |
| Start date | 18 June 2019 |
| Primary completion | 22 January 2020 |
| Estimated completion | 22 January 2020 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Dragon fruit juice drink
- Placebo
Conditions studied
- Healthy Men and Women — all drugs for Healthy Men and Women →
Sponsor
King's College London
Who can join
Adults 18 to 40, any sex, with Healthy Men and Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Native to South America and South East Asia, the dragon fruit (pitaya) has become increasingly popular world-wide due to their vivid hue and bizarre structure. More importantly, their high levels of bioactive phytochemical betalains has sparked considerable scientific interest. Recent findings from in vitro and in vivo animal studies tentatively suggest that betalains may have ameliorative effects on vascular function. This will be a first randomised controlled trial aimed to explore the impact of dragon fruit consumption on blood pressure and other vascular parameters in healthy individuals. The study will feature a randomised, double-blinded, placebo-controlled and crossover design with flow-mediated dilatation (FMD) as primary outcome along with blood pressure and arterial stiffness as secondary outcomes. Cardiovascular biomarkers as well as relevant metabolites will also be determined from blood and urine samples collected from participants.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
Betalain-rich dragon fruit (pitaya) consumption improves vascular function in men and women: a double-blind, randomized controlled crossover trial.
Cheok A, Xu Y, Zhang Z, Caton PW, et al · · 2022 · cited 18× · PMID 35265960 · DOI 10.1093/ajcn/nqab410 -
Development of a (Poly)phenol Metabolic Signature for Assessing (Poly)phenol-Rich Dietary Patterns.
Li Y, Xu Y, Le Sayec M, Yan X, et al · · 2024 · cited 6× · PMID 38829321 · DOI 10.1021/acs.jafc.4c00959 -
Development of metabolic signatures of plant-rich dietary patterns using plant-derived metabolites.
Li Y, Xu Y, Sayec ML, Spector TD, et al · · 2024 · cited 2× · PMID 39604558 · DOI 10.1007/s00394-024-03511-x
Verify or expand the search:
- PubMed search for NCT03995602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other King's College London trials
Trials by the same sponsor.
- NCT07357064 — Professional Decision Making in Childbirth. · not yet recruiting
- NCT07341087 — Skin Inflammation in Perimenopause: A Probiotic Intervention Proof of Concept Trial · NA · recruiting
- NCT07228962 — Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in Babies · not yet recruiting
- NCT07365722 — Comparison of Two Non-surgical Procedure to Manage Gum Disease Around Implants. · NA · not yet recruiting
- NCT07378488 — Dance/Movement Therapy for Functional Neurological Disorder · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03995602 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by King's College London
- Last refreshed: 7 June 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03995602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing